Author:
Gillette Chris,Locklear Tony,Bell Ronny,Bates Nathan,Ostermann Jan,Reuland Daniel,Foley Kristie,Lashmit Cheyenne,Crandall Sonia
Abstract
Abstract
Purpose
(1) Identify the proportion of primary care visits in which American Indian/Alaska Native (AI/AN) men receive a prostate-specific antigen test (PSAT)and/or a digital rectal exam (DRE), (2) describe characteristics of primary care visits in which AI/AN receive PSA and/or DRE, and (3) identify whether AI/AN receive PSA and/or DRE less often than non-Hispanic White (nHW) men.
Methods
This was a secondary analysis of the National Ambulatory Medical Care Survey (NAMCS) during 2013–2016 and 2018 and the NAMCS Community Health Center (CHC) datasets from 2012–2015. Weighted bivariate and multivariable tests analyzed the data to account for the complex survey design.
Results
For AI/AN men, 1.67 per 100 visits (95% CI = 0–4.24) included a PSATs (or PSAT) and 0 visits included a DRE between 2013–2016 and 2018. The rate of PSA for non-AI/AN men was 9.35 per 100 visits (95% CI = 7.78–10.91) and 2.52 per 100 visits (95% CI = 1.61–3.42) for DRE. AI/AN men were significantly less likely to receive a PSA than nHW men (aOR = 0.09, 95% CI = 0.01–0.83). In CHCs, AI/AN men experienced 4.26 PSAT per 100 visits (95% CI = 0.96–7.57) compared to 5.00 PSAT per 100 visits (95% CI = 4.40–5.68) for non-AI/AN men. DRE rates for AI/AN men was 0.63 per 100 visits (95% CI = 0–1.61) compared to 1.05 per 100 (95% CI = 0.74–1.37) for non-AI/AN men. There was not a statistically significant disparity in the CHC data regarding PSA (OR = 0.91, 95% CI = 0.42–1.98) or DRE (OR = 0.75, 95% CI = 0.15–3.74), compared to nHW men.
Conclusion
Efforts are needed to better understand why providers may not use PSA and DRE with AI/AN men compared to nHW men.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Jones N (2022) 2020 Census results on race and ethnicity. https://www.census.gov/content/dam/Census/newsroom/press-kits/2021/redistricting/20210812-presentation-redistricting-jones.pdf. Accessed 7 July 2022
2. Melkonian SC, Weir HK, Jim MA, Preikschat B, Haverkamp D, White MC (2021) Incidence of and trends in the leading cancers with elevated incidence among American Indian and Alaska Native populations. Am J Epidemiol 190(4):428–438
3. Cancer and American Indians/Alaska Natives. https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=31. Accessed 7 July 2022
4. Siegel DA, O'Neil ME, Richards TB, Dowling NF, Weir HK (2022) Prostate cancer incidence and survival, by stage and race/ethnicity-United States, 2001–2017. Morbidity and Mortality Weekly Report. https://www.cdc.gov/mmwr/volumes/69/wr/mm6941a1.htm. Accessed 7 July 2022
5. Deuker M, Knipper S, Pecoraro A et al (2020) Prostate cancer characteristics and cancer-specific mortality of Native American patients. Prostate Cancer Prostatic Dis 23(2):277–285